Highlights
- Sales over the Year and quarter: The company’s sales declined by -89.52 % over the year, decrease in net sales/revenue by -89.51 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -91.59 %, Marginal decrease of -96.36% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for JUBILANT PHARMOVA LIMITED. Profit dropped by -93.85 % Year to Year, JUBILANT PHARMOVA LIMITED’s profitability dropped by -109.31 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -40.00 % Year to Year. EPS decreased by -187.44 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1678 Cr | Rs. 1677.1 Cr | Rs. 175.86 Cr | -89.51 % | -89.52 % |
| Expenses | Rs. 1458.78 Cr | Rs. 1459.1 Cr | Rs. 148.72 Cr | -89.81 % | -89.81 % |
| Operating Profit | Rs. 219.22 Cr | Rs. 218 Cr | Rs. 27.14 Cr | -87.55 % | -87.62 % |
| OPM % | 13.06 % | 13 % | 15.43 % | + 2.43 % | + 2.37 % |
| Other Income | Rs. 21.16 Cr | Rs. 48.9 Cr | Rs. 1.78 Cr | -96.36 % | -91.59 % |
| Interest | Rs. 55.56 Cr | Rs. 71.3 Cr | Rs. 7.3 Cr | -89.76 % | -86.86 % |
| Depreciation | Rs. 271.23 Cr | Rs. 94.6 Cr | Rs. 10.1 Cr | -89.32 % | -96.28 % |
| Profit before tax | Rs. -86.41 Cr | Rs. 101 Cr | Rs. 11.52 Cr | -88.59 % | + 113.33 % |
| Tax % | -13.67 % | 39.36 % | -14.19 % | -53.55 % | -0.52 % |
| Net Profit | Rs. -100.51 Cr | Rs. 66.4 Cr | Rs. -6.18 Cr | -109.31 % | + 93.85 % |
| EPS in Rs | Rs. -6.15 | Rs. 4.2 | Rs. -3.68 | -187.62 % | + 40.16 % |
Today, we’re looking at JUBILANT PHARMOVA LIMITED’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -89.52 %. However, it did see a marginal slip of -89.51 % from the previous quarter. Expenses decreased slightly by -89.81 % quarter-on-quarter, aligning with the annual decline of -89.81 %. Operating profit, while down -87.62 % compared to last year, faced a quarter-on-quarter dip of -87.55 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.37 %, but an expansion of 2.43 % sequentially. Other income fell by -96.36 % compared to the last quarter, despite an annual decline of -91.59 %. Interest expenses dropped significantly by -89.76 % from the previous quarter, yet the year-over-year decrease remains at a moderate -86.86 %. Depreciation costs fell by -89.32 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -96.28 %. Profit before tax grew annually by 113.33 % but saw a reduction from the preceding quarter by -88.59 %.
Tax expenses as a percentage of profits decreased slightly by -0.52 % compared to last year, with a more notable quarter-on-quarter decrease of -53.55 %. Net profit rose by 93.85 % year-on-year but witnessed a -109.31 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 40.16 % but a quarterly fall of -187.62 %. In summary, JUBILANT PHARMOVA LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1678 Cr | Rs. 1677.1 Cr | Rs. 175.86 Cr | -89.51 % | -89.52 % |
| Expenses | Rs. 1458.78 Cr | Rs. 1459.1 Cr | Rs. 148.72 Cr | -89.81 % | -89.81 % |
| Operating Profit | Rs. 219.22 Cr | Rs. 218 Cr | Rs. 27.14 Cr | -87.55 % | -87.62 % |
| Net Profit | Rs. -100.51 Cr | Rs. 66.4 Cr | Rs. -6.18 Cr | -109.31 % | + 93.85 % |
| EPS in Rs | Rs. -6.15 | Rs. 4.2 | Rs. -3.68 | -187.62 % | + 40.16 % |
In reviewing JUBILANT PHARMOVA LIMITED’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -89.52 % year-on-year, although there was a slight dip of -89.51 % from the previous quarter. Expenses decreased by -89.81 % compared to the previous year, with a decrease of -89.81 % quarter-on-quarter. Operating Profit dropped by -87.62 % annually, and saw a -87.55 % decrease from the last quarter.
Net Profit showed yearly increase of 93.85 %, and experienced a -109.31 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 40.16 % annually, however dipped by -187.62 % compared to the last quarter. In essence, while JUBILANT PHARMOVA LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
